Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47.9M
-
Number of holders
-
273
-
Total 13F shares, excl. options
-
49.4M
-
Shares change
-
-1.14M
-
Total reported value, excl. options
-
$4.42B
-
Value change
-
-$131M
-
Put/Call ratio
-
3.75
-
Number of buys
-
156
-
Number of sells
-
-132
-
Price
-
$89.56
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2020
331 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q2 2020.
HAEMONETICS CORP - Common Stock (HAE) has 273 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.4M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (5.3M shares), BlackRock Inc. (5.1M shares), Capital Research Global Investors (3.99M shares), Neuberger Berman Group LLC (3.1M shares), Jackson Square Partners, LLC (2.3M shares), RENAISSANCE TECHNOLOGIES LLC (2.19M shares), FMR LLC (1.79M shares), WELLINGTON MANAGEMENT GROUP LLP (1.54M shares), FRANKLIN RESOURCES INC (1.28M shares), and STATE STREET CORP (1.26M shares).
This table shows the top 273 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.